DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Larsen ML, Grove EL, Kristensen SD, Hvas A-M.
Benefits and harm of treatment with P2Y12-inhibitors beyond 12 months in patients with coronary artery disease.
Semin Thromb Hemost 2020;
46 (04) 446-456
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.